-
-
With Thousands of Families Painting the “Fosun Lifestyle”, the 6th 515 Fosun Family Day is in Full Swing
2024-05-16
On 15 May, a massive scroll unfurled in the central square of Yuyuan Garden in Shanghai. Close to a hundred families collectively painted the "Fosun lifestyle" scroll, illuminating the "star of Fosun". At the same time, thousands of families painted the "Fosun lifestyle" scroll in 20 commercial districts and communities such as Shanghe Yinxiang in Ru
-
-
Fosun International Earns a Spot on “2024 Fortune China ESG Impact List”
2024-05-16
On 13 May 2024, Fortune China magazine released the 2024 China ESG Impact List, and Fosun International Limited (“Fosun International”or the “Company”) (HKEX stock code: 00656) was included in the list, highlighting its outstanding performance and industry leadership in the areas of environmental, social and governance (ESG).FortuneChinapointed out
-
-
Guo Guangchang Meets Chinese Ambassador to France, Lu Shaye, in Paris and Attends 'Choose France' Business Summit
2024-05-15
On May 14th, Guo Guangchang, Chairman of Fosun International, along with a delegation, paid a visit to the Chinese Embassy in Paris, where they met with the Chinese Ambassador to France, Lu Shaye. Economic and Commercial Minister Counselor Shen Xiang from the embassy was also in attendance.Guo Guangchang introduces Fosun’s operation in France in meet
-
-
"Mission Accomplished! The Visionary 'Charity Ambassador's' U.S. Trip"
2024-05-09
Visiting international organizations, experiencing a variety of exciting workshops, touring museums and art galleries, city walks through the streets of New York, and interesting soul collisions...The 2024 Emerging Visionaries Awards “Charity Ambassadors” Zheyi Yeand Ko Cheng-ruei, have successfully completed their trip to the USA. What do they have to s
-
-
Henlius Dual HER2 Blockade Therapy Receives Phase 3 MRCT IND Approval from U.S. FDA
2024-05-06
Shanghai, China, May 6, 2024-Shanghai Henlius Biotech, Inc. (2696.HK) announced that the investigational new drug application (IND) for phase 3 international multicenter clinical study of Henlius’ novel anti-HER2 mAb, HLX22, in combination with trastuzumab and chemotherapy for the first-line treatment of HER2-positive advanced gastric cancer has been approve
-
-
Henlius Trastuzumab Receives FDA Approval in the United States
2024-04-26
·HLX02 (trastuzumab-strf, trade name: HANQUYOU in China, HERCESSI™ in the U.S. and Zercepac®in Europe) is a China-developed mAb biosimilar approved in China, Europe, and U.S.·HLX02 was approved in more than 40 countries and regions around the world, benefiting more than 180,000 patients·Henlius accelerates global expansion, delivering
-
-
Fosun for Good, Creating IMPACT: Fosun International Issued its 2023 ESG Report and the Second Climate Information Disclosures Report
2024-04-26
(Hong Kong, 26 April 2024) Fosun International Limited (HKEX stock code: 00656, “Fosun International”), together with its subsidiaries (“Fosun” or the “Group”), today issued the Environmental, Social and Governance (ESG) Report 2023 (the “ESG Report”).Facing the increasingly severe challenges of global climate change, Fosun released its second
-
-
Fosun Pharma’s Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa
2024-04-25
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024Accelerating the fight against malaria for a more equitable world.WHO stated that malaria not only continues to directly endanger health and cost lives, but it also perpetuates a vicious cycle of inequity. People living in the most vulnerable situations inclu
-
-
Wang Qunbin: Fosun Adheres to Globalization Strategy and Continuous Innovation to Create New Momentum
2024-04-22
The Standard Chartered China Summit 2024, hosted by Standard Chartered, was held on 10 April at the Peninsula Shanghai. Wang Qunbin, Co-Chairman of Fosun International, attended the summit and participated in the Fireside Chat Session, where he shared insights on innovation and disruption in a new pattern of global economic development, drawin